ARDX
Price
$4.70
Change
+$0.10 (+2.17%)
Updated
Jul 10 closing price
Capitalization
1.1B
20 days until earnings call
DOMH
Price
$4.78
Change
-$0.19 (-3.82%)
Updated
Jul 10 closing price
Capitalization
72.78M
39 days until earnings call
Interact to see
Advertisement

ARDX vs DOMH

Header iconARDX vs DOMH Comparison
Open Charts ARDX vs DOMHBanner chart's image
Ardelyx
Price$4.70
Change+$0.10 (+2.17%)
Volume$4.17M
Capitalization1.1B
Dominari Holdings
Price$4.78
Change-$0.19 (-3.82%)
Volume$129.85K
Capitalization72.78M
ARDX vs DOMH Comparison Chart in %
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. DOMH commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and DOMH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ARDX: $4.70 vs. DOMH: $4.78)
Brand notoriety: ARDX and DOMH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 84% vs. DOMH: 41%
Market capitalization -- ARDX: $1.1B vs. DOMH: $72.78M
ARDX [@Biotechnology] is valued at $1.1B. DOMH’s [@Biotechnology] market capitalization is $72.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileDOMH’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • DOMH’s FA Score: 0 green, 5 red.
According to our system of comparison, ARDX is a better buy in the long-term than DOMH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 4 TA indicator(s) are bullish while DOMH’s TA Score has 4 bullish TA indicator(s).

  • ARDX’s TA Score: 4 bullish, 5 bearish.
  • DOMH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARDX is a better buy in the short-term than DOMH.

Price Growth

ARDX (@Biotechnology) experienced а +10.07% price change this week, while DOMH (@Biotechnology) price change was -9.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ARDX is expected to report earnings on Oct 30, 2025.

DOMH is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($1.1B) has a higher market cap than DOMH($72.8M). DOMH YTD gains are higher at: 405.294 vs. ARDX (-7.298). ARDX has higher annual earnings (EBITDA): -28.23M vs. DOMH (-40.28M). ARDX has more cash in the bank: 214M vs. DOMH (18.9M). DOMH has less debt than ARDX: DOMH (2.92M) vs ARDX (155M). ARDX has higher revenues than DOMH: ARDX (362M) vs DOMH (24.9M).
ARDXDOMHARDX / DOMH
Capitalization1.1B72.8M1,512%
EBITDA-28.23M-40.28M70%
Gain YTD-7.298405.294-2%
P/E RatioN/AN/A-
Revenue362M24.9M1,454%
Total Cash214M18.9M1,132%
Total Debt155M2.92M5,314%
FUNDAMENTALS RATINGS
ARDX vs DOMH: Fundamental Ratings
ARDX
DOMH
OUTLOOK RATING
1..100
2682
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
5035
P/E GROWTH RATING
1..100
51100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DOMH's Valuation (73) in the null industry is in the same range as ARDX (97) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ARDX’s over the last 12 months.

DOMH's Profit vs Risk Rating (100) in the null industry is in the same range as ARDX (100) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's SMR Rating (96) in the Biotechnology industry is in the same range as DOMH (98) in the null industry. This means that ARDX’s stock grew similarly to DOMH’s over the last 12 months.

DOMH's Price Growth Rating (35) in the null industry is in the same range as ARDX (50) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's P/E Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for DOMH (100) in the null industry. This means that ARDX’s stock grew somewhat faster than DOMH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXDOMH
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend about 1 month ago
82%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQIAX32.80N/A
N/A
BNY Mellon Equity Income Fund A
PGWIX12.40N/A
N/A
Principal MidCap Growth Inst
JFCIX38.65N/A
N/A
JHancock Fundamental All Cap Core I
ACCLX15.80N/A
N/A
American Century Mid Cap Value C
MFMLX16.67N/A
N/A
Morgan Stanley Inst Next Gen Em Mkts L

DOMH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DOMH has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if DOMH jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOMH
1D Price
Change %
DOMH100%
-3.82%
AXON - DOMH
36%
Loosely correlated
-9.04%
EDSA - DOMH
35%
Loosely correlated
-1.66%
FHTX - DOMH
32%
Poorly correlated
-2.00%
ARDX - DOMH
31%
Poorly correlated
+2.17%
ENTA - DOMH
29%
Poorly correlated
-2.10%
More